Chemotherapy-free Treatment

Eazi Business • May 10, 2019

Hope for Leukaemia Patients with chemotherapy free treatment

We have some very exciting news this month at Hope Against Cancer! Our researchers at the Clinical Trials Facility have shown some promising results for patients with Chronic Lymphocytic Leukaemia (CLL). This study was led by our very own Hope funded researcher, Professor Martin Dyer and it may well see a future where patients can receive treatment without the daunting prospect of chemotherapy.

So, what is CLL?

It is actually THE most common form of adult chronic leukaemia, where chemotherapy is usually used to treat it. However, sometimes this isn’t a suitable option for some patients who might have other health issues.

What’s the solution?

Well, researchers have combined a protein called BCL2, which kills the CLL cells, with another drug called Obinutuzumab. The result of this combination has been effective and found a 95% remission rate from those who were treated at the Clinical Trials Facility. This remission showed that there were no signs of leukaemia in the patients’ blood or scans and they didn’t have any symptoms.

The Expert

The results for patients who took part in the clinical trial have been exceptional, it’s also fantastic to see that they haven’t had to go through the gruelling process, or encounter the side effects, of chemo-therapy. Hope funded researcher, Professor Martin Dyer, is a professor of haemato-oncology and is the director of the Ernest and Helen Scott Haematology Research Institute at the University of Leicester. He has said that “The high response rates and remissions have made us optimistic that this treatment could become a standard of care of CLL patients in the future.” Here at Hope we feel that we have been incredibly lucky to have Professor Dyer’s expertise and knowledge to pull off such great results.

Our Chief Executive, Nigel Rose has said: “We are thrilled to see such incredible results coming from our Clinical Trials Facility. It is always a proud moment when we’re involved in funding research that has such a great potential impact on future treatments! It shows how important our funding is and without the fantastic support from the people of Leicestershire and Rutland who fundraise, donate and take part in Hope’s events, it simply wouldn’t be possible.”


If you want to find out more information about the Hope Against Cancer Clinical Trials Facility, then you can click here . To get involved in supporting vital research projects like this then you can help us by fundraising! Every penny counts and any amount raised is massively appreciated by the Hope team. For more information on how to help us beat cancer – click here !


By John Nellis March 3, 2025
"I wanted to stay Emma, I wanted to stay myself, to feel as much myself as I could."
By John Nellis February 13, 2025
An interview with John Edgar from North Kilworth Wharf
By John Nellis January 16, 2025
I had mentally prepared myself - I am just the type to think, ‘ok - this is what I have to do, so let’s get started’.
By John Nellis December 11, 2024
“It is the biggest emotional rollercoaster I’ve ever been on." 
By John Nellis November 8, 2024
Hope Ambassador Alice Greaves wins the Furnley House Community Champions Award for Fundraiser of the Year
By John Nellis October 4, 2024
We recently met Ian for a coffee at the RVS café at the Leicester Royal Infirmary, his wife Ellena is coming to the end of a trial at the Hope Cancer Trials Centre and he is in remission having received treatment for prostate cancer at the Osborne Building. Ian generously donates to HOPE and wanted to share their story with us .
By John Nellis September 6, 2024
On 1 st September thousands of runners took part in the London Big Half Marathon. Among the crowds were 18 incredible people taking part to raise money for Hope Against Cancer. The 13.1 mile course took the runners on a journey across London starting at Tower Bridge and ending at the iconic Cutty Sark in Greenwich. The event began at 8.25am with the start of the elite wheelchair race. This was closely followed by the elite runners and then the first mass wave. Dame Kelly Holmes led the elite runners off the start line. HOPE’s own Corporate and Community Partnerships Manager, Tim Gorman-Powell, ran in elite group A… Tim said, “I’m not sure how or why I found myself in that group but I enjoyed running alongside the best of the best for the short time I did so!” The sun was shining and spirits were high. The atmosphere was amazing as thousands of friends and family roared on the 10,000+ runners through the streets of London. The finish line was packed with spectators and reverberated to the loud music playing over the PA system. Tim concludes that it was “an incredible event from start to finish, with a great atmosphere and a beautiful route through the capital.” The HOPE runners not only raised thousands for cancer research and trials support but they also had a wonderful day. Here is some of their feedback: "It was a pleasure to run the Big Half in aid of Hope Against Cancer with a wonderful amount of money raised so far!" "I can't put it into words, it was so hot and hard but I LOVED IT!! Thank you so much for this amazing experience" "Great day running in London for Hope Against Cancer" "Enjoyable day in the capital with a great group of people all running for Hope Against Cancer. I even set a new half marathon PB!!!" We would like to extend a heartfelt thank you to everyone that made the trip to support Hope Against Cancer and life changing cancer research and clinical trials here in Leicestershire and Rutland.
By John Nellis July 24, 2024
A Hope Against Cancer Press Release
By John Nellis June 6, 2024
We recently sat down with Hope’s longest serving volunteer Dorothy Tomlinson to talk a little bit about her time with the charity.
A man wearing glasses and a blue shirt is smiling for the camera.
By John Nellis May 15, 2024
I believe that my experience with CLL (Chronic Lymphocytic Leukaemia) was fairly typical. It all began with an insurance policy blood test which showed a slightly raised white blood cell count that I needed to discuss with my GP. A referral to Leicester Royal Infirmary led to a diagnosis of CLL in July 2019. ‘A classic case’ the consultant said. I was 73 and it was a diagnosis by chance rather than by symptoms. The CLL was not that advanced and the doctors told me that there was no advantage to early treatment for this particular form of cancer. I was given reams of literature about the disease, which included plenty of optimistic comments about the success rates of the latest treatment, and I was put on Watch and Wait status. I soon learned that this is more realistically called Watch and Worry… I was also likely to be more prone to infection, and with COVID just around the corner, I became socially ultra cautious. I watched and I waited for three years, with blood tests every three months and ongoing discussions with my excellent consultant Dr Allchin. Dr Allchin was very clear about how the disease was progressing, realistic, but positive nevertheless. It was particularly helpful that my wife was able to attend all the sessions and that I could record them on my phone. In Autumn 2022 the tests revealed that it was time to start my treatment and I was given all the information I needed to make my own decision. I had two options. For me it was either take tablets for the rest of my life or a one-year treatment that would involve hospital visits. I chose the one year 'targeted therapy’ option. This is one of the new cancer treatments that research by centres such as the Hope Cancer Trials Centre has made possible. To begin I was given monthly infusions at the Osborne Day Centre at the Leicester Royal Infirmary. The nurses were superb, and the atmosphere was positive. This lasted approximately 6 months and while I was very tired for much of the time, there were not too many side effects. The treatment does affect your immune system so, in normal circumstances I would have needed to minimise social mixing, but the impact of COVID was having a similar effect anyway. The other part of my treatment was tablet-based which built to a crescendo of four large pills every day for ten months. This overlapped with the infusions, so that it was all completed within the same year. I received regular support from my consultant, from my CLL nurses (Sarah and Tina), from the Osborne Clinic nurses, and from the 24/7 Haematology helpline, and all this at an incredibly difficult time for every part of the NHS. My targeted therapy, which both enabled my immune system to recognise and fight the cancer, and attacked the disease itself, is a massive improvement on the earlier invasive treatments. To me, this clearly shows the progress made in cancer therapy thanks to research by organisations like Hope against Cancer. It was obvious how expensive all this is, especially as improvements are made in the effectiveness of treatment. Fundraising is a vital element in making these improvements possible. After I was told I was in remission I wanted to show my gratitude for the support I received at the LRI and donated to Hope Against Cancer to help support the incredible work of the Hope Cancer Trials Centre.
More Posts